Search results
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 4 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
This startup uses overseas freelancers to help Americans find Adderall and Ozempic
Quartz· 2 days agoA startup is working to help Americans navigate ongoing shortages of highly-coveted drugs like...
NHL, NHLPA partner with V Foundation for Cancer Research for $2.9 million donation | NHL.com
NHL· 6 days agoThe NHL and NHL Players' Association, together with the V Foundation for Cancer Research, have...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 21 hours agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...
Significant Benefit With Liver Transplantation in ACLF
Medscape· 21 hours agoLiver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 7 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Factbox-Battles over CEO pay across the globe
Investing.com· 21 hours agoMusk said late on Wednesday that shareholders were voting by wide margins to approve the pay package. Musk's proposed pay package, the largest in...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 3 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 4 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 7 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.